MAP
BLFS icon

Moody Aldrich Partners’s BioLife Solutions BLFS Stock Holding History

Moody Aldrich Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,820
Closed -$2.29M – 160
2022
Q3 		$2.29M Sell
100,820
-83,638
-45% -$1.79M 0.47% 71
2022
Q2 		$2.55M Sell
184,458
-36,222
-16% -$532K 0.5% 75
2022
Q1 		$5.02M Buy
220,680
+25,984
+13% +$684K 0.71% 57
2021
Q4 		$7.26M Sell
194,696
-39,091
-17% -$1.68M 1.01% 46
2021
Q3 		$9.89M Buy
+233,787
New +$11.3M 1.26% 21

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Moody Aldrich Partners's BLFS Position: Q4 2022 in Review

Moody Aldrich Partners sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 100,820 shares — an estimated $2.29M sold.

Moody Aldrich Partners first reported a position in BLFS in Q3 2021 and held it in 5 quarters. The position peaked at $9.89M in Q3 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

  • Moody Aldrich Partners reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
  • Moody Aldrich Partners sold 100,820 BioLife Solutions shares in Q4 2022, an estimated $2.29M.
  • Moody Aldrich Partners first reported a position in BioLife Solutions in Q3 2021 and held it in 5 quarters.
  • Moody Aldrich Partners's BioLife Solutions position peaked at $9.89M in Q3 2021.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Moody Aldrich Partners's 13F filing for Q4 2022, filed 24 Jan 2023.